Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
Status:
Recruiting
Trial end date:
2029-06-30
Target enrollment:
Participant gender:
Summary
To compare the effectiveness and toxicity of nedaplatin versus cisplatin in induction
chemotherapy combined with concurrent chemoradiotherapy for locoregionally advanced
nasopharyngeal carcinoma.
Phase:
Phase 3
Details
Lead Sponsor:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University